Literature DB >> 8011994

[The spiral CT of cervical lymph node enlargements. The initial clinical results].

H J Steinkamp1, U Keske, J Schedel, N Hosten, R Felix.   

Abstract

Spiral CT was performed before treatment in 35 patients with suspected cervical lymph node enlargement. By coronary and sagittal reconstruction it is possible to utilise the M/Q quotient which has become accepted as the result of sonographic and MRI examinations. It is now possible to obtain high diagnostic accuracy (97%) for distinguishing between reactive change from metastatic infiltration of lymph nodes (> 8 mm) by using CT. Using spiral CT with 5 mm table movement, three patients diagnosed as stage N1 by axial CT were shown to be N2b. This represents a highly sensitive and highly specific method of lymph node diagnosis. Further diagnostic improvement derives from the ability to relate the lymph nodes to surrounding tissues. Spiral CT is also suitable for defining other space occupying lesions, e.g., the exact extent of retropharyngeal abscesses, abnormalities of the salivary glands or laryngoceles.

Entities:  

Mesh:

Year:  1994        PMID: 8011994     DOI: 10.1055/s-2008-1032467

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  2 in total

1.  TNM staging with FDG-PET/CT in patients with primary head and neck cancer.

Authors:  Patrick Veit-Haibach; Christopher Luczak; Isabel Wanke; Markus Fischer; Thomas Egelhof; Thomas Beyer; Gerlinde Dahmen; Andreas Bockisch; Sandra Rosenbaum; Gerald Antoch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-08-24       Impact factor: 9.236

2.  Combined PET/CT-perfusion in patients with head and neck cancers might predict failure after radio-chemotherapy: a proof of concept study.

Authors:  Carsten Pietsch; Felipe de Galiza Barbosa; Martin W Hüllner; Daniel T Schmid; Stephan K Haerle; Gerhard F Huber; Gabriela Studer; Thomas F Hany; Patrick Veit-Haibach
Journal:  BMC Med Imaging       Date:  2015-12-29       Impact factor: 1.930

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.